The weight loss gleaned from the drug is quite modest, about 5 kilograms, said Dr. Timothy Pfanner, an assistant professor of internal medicine at the Texas A&M Health Science Center College of Medicine and a gastroenterologist with Scott & White, in Temple, Texas.

…

The issue is complicated by the fact that some patients are taking the drug in its over-the-counter form, meaning they are likely not being tracked and monitored by doctors for side effects.

At this point, there is no reason for consumers to stop taking the drug if they’re already on it — as long as they’re using it as recommended — and no reason for physicians to stop prescribing it, U.S. Food and Drug Administration officials stressed Monday.

Link to the full article: http://health.yahoo.com/news/healthday/fdainvestigatingweightlossdrugoverreportsofliverdamage.html

Here is to your health!

Mohamed

Technorati Tags: fda, liver damage, orlistat